| Turquia | Austria | Spanyol | |
| Terapi sinar proton | dari $70,000 | dari $80,000 | dari $25,975 |
| Terapi proton untuk kanker prostat | dari $30,000 | dari $80,000 | dari $70,000 |
| Terapi proton untuk kanker payudara | dari $30,000 | dari $55,000 | dari $85,000 |
| Reseksi tulang | dari $8,000 | dari $25,000 | dari $20,000 |
| Kemoterapi untuk kanker payudara | dari $1,200 | dari $15,000 | dari $3,500 |
Penulis dari lebih dari 40 publikasi yang ditinjau sejawat dalam biologi tumor/imunologi dan terapi sistemik (imunoterapi dan terapi terarah); anggota dari Asosiasi Onkologi Medis Turki dan European Head & Neck Society.
Alasan pasien memilih Dr. Bülent Karagöz:
Dr. Mustafa Solak berspesialisasi dalam mengobati berbagai jenis kanker, termasuk kasus langka seperti Kondrosarkoma, di Rumah Sakit Interkontinental Hisar.
Dr. Mehmet Taner Ozdemir is an experienced orthopedic specialist with 7 years in the field. He focuses on oncology, orthopedic trauma, arthroscopic surgery, and bone and soft tissue tumors. He completed his medical and specialist training at GATA Faculty of Medicine in Ankara. He also received advanced training at the Hospital for Special Surgery in New York, USA.
Dr. Ozdemir is a member of the Turkish Orthopedics and Traumatology Association and the European Musculoskeletal Tumor Society. He has written five national and thirteen international publications. He is dedicated to improving orthopedic science. His skills include joint replacements, arthroscopies, and tumor surgeries.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.